Analysis | Metabolite Name | Measured Value | Units | Cell Type | Stimulation |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M-H)- | 1415178 | Peak area | PAK | IFN-G |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M-H)- | 1476367 | Peak area | PAK | IL-17A |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M-H)- | Peak area | BS4 | IFN-G | |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M-H)- | Peak area | BS4 | IL-17A | |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M-H)- | Peak area | BS4 | TNF-alpha | |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M-H)- | Peak area | BS4 | TNF-alpha+IL-17A | |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M-H)- | Peak area | BS4 | Untreated | |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M-H)- | Peak area | HAHA | IFN-G | |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M-H)- | Peak area | HAHA | IL-17A | |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M-H)- | Peak area | HAHA | TNF-alpha | |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M-H)- | Peak area | HAHA | TNF-alpha+IL-17A | |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M-H)- | Peak area | HAHA | Untreated | |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M-H)- | Peak area | PAK | TNF-alpha | |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M-H)- | Peak area | PAK | TNF-alpha+IL-17A | |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M-H)- | Peak area | PAK | Untreated | |
Reversed phase POSITIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M+NA)+ | 2122 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M+NA)+ | 3641 | Peak area | BS4 | IL-17A |
Reversed phase POSITIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M+NA)+ | Peak area | BS4 | IFN-G | |
Reversed phase POSITIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M+NA)+ | Peak area | BS4 | TNF-alpha | |
Reversed phase POSITIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M+NA)+ | Peak area | BS4 | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M+NA)+ | Peak area | BS4 | Untreated | |
Reversed phase POSITIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M+NA)+ | Peak area | HAHA | IFN-G | |
Reversed phase POSITIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M+NA)+ | Peak area | HAHA | IL-17A | |
Reversed phase POSITIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M+NA)+ | Peak area | HAHA | TNF-alpha | |
Reversed phase POSITIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M+NA)+ | Peak area | HAHA | Untreated | |
Reversed phase POSITIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M+NA)+ | Peak area | PAK | IFN-G | |
Reversed phase POSITIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M+NA)+ | Peak area | PAK | IL-17A | |
Reversed phase POSITIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M+NA)+ | Peak area | PAK | TNF-alpha | |
Reversed phase POSITIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M+NA)+ | Peak area | PAK | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | GLUTAMINE (CAS# 56-85-9); (M+NA)+ | Peak area | PAK | Untreated |